Sherly I. Celada

Statistics

Publications

Citations

122

H-Index

Active since

2020

Affiliations

Vanderbilt University Medical Center(Current)

Meharry Medical College

Tennessee State University

University of Mississippi Medical Center

Sherly I. Celada is an author at Vanderbilt University Medical Center specializing in prostate cancer, molecular biology, and prostate carcinogenesis.

ORCID

Publications per year

2020–2023

Publications

MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway

Thanigaivelan Kanagasabai, Guoliang Li, Tian Shen et al. · Cancer Letters · 2021 · 57 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis

Guoliang Li, Thanigaivelan Kanagasabai, Wenfu Lu et al. · Cancer Research · 2020 · 52 citations · Full text

Medicine, Genetics, Molecular Biology +17

Lysosome‐dependent <scp>FOXA1</scp> ubiquitination contributes to luminal lineage of advanced prostate cancer

Sherly I. Celada, Guoliang Li, Lindsay J. Celada et al. · Molecular Oncology · 2023 · 13 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–3 of 3